Flutiform Approval Status
- FDA approved: No
- Brand name: Flutiform
- Generic name: formoterol and fluticasone
- Company: SkyePharma PLC
- Treatment for: Asthma
Flutiform (formoterol and fluticasone) metered dose inhaler is a long-acting beta-agonist and corticosteroid fixed-dose combination in development for the treatment of asthma.
Development Status and FDA Approval Process for Flutiform
|Jun 10, 2009||SkyePharma PLC - Flutiform U.S. Filing Update|
|May 22, 2009||Skyepharma plc: Flutiform NDA Accepted for Review|
|Aug 6, 2007||SkyePharma PLC - Flutiform Progress Update|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.